Noevir Holdings Co., Ltd. (4928.T)
JPY 4895.0
(1.03%)
JPY 4895.0
(1.03%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 62.55 Billion JPY | 2.3% |
| 2022 | 61.14 Billion JPY | 19.25% |
| 2021 | 51.27 Billion JPY | -1.1% |
| 2020 | 51.84 Billion JPY | -12.51% |
| 2019 | 59.25 Billion JPY | 2.46% |
| 2018 | 57.82 Billion JPY | 6.16% |
| 2017 | 54.47 Billion JPY | 6.43% |
| 2016 | 51.18 Billion JPY | 3.63% |
| 2015 | 49.38 Billion JPY | 2.35% |
| 2014 | 48.25 Billion JPY | 3.73% |
| 2013 | 46.51 Billion JPY | -1.49% |
| 2012 | 47.22 Billion JPY | 0.0% |
| 2011 | - JPY | -100.0% |
| 2010 | 52.58 Billion JPY | -4.79% |
| 2009 | 55.22 Billion JPY | -5.87% |
| 2008 | 58.66 Billion JPY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 16.61 Billion JPY | 6.02% |
| 2024 Q2 | 15.01 Billion JPY | -9.65% |
| 2024 Q3 | 16.61 Billion JPY | 10.67% |
| 2023 Q3 | 15.98 Billion JPY | 8.84% |
| 2023 Q4 | 15.67 Billion JPY | -1.98% |
| 2023 Q1 | 16.2 Billion JPY | 6.27% |
| 2023 FY | 62.55 Billion JPY | 2.3% |
| 2023 Q2 | 14.68 Billion JPY | -9.38% |
| 2022 Q4 | 15.25 Billion JPY | -3.05% |
| 2022 FY | 61.14 Billion JPY | 19.25% |
| 2022 Q3 | 15.73 Billion JPY | 7.82% |
| 2022 Q2 | 14.59 Billion JPY | -6.3% |
| 2022 Q1 | 15.57 Billion JPY | 25.11% |
| 2021 FY | 51.27 Billion JPY | -1.1% |
| 2021 Q4 | 12.44 Billion JPY | -4.01% |
| 2021 Q1 | 13.87 Billion JPY | 14.45% |
| 2021 Q2 | 11.98 Billion JPY | -13.58% |
| 2021 Q3 | 12.96 Billion JPY | 8.16% |
| 2020 Q1 | 15.46 Billion JPY | 5.71% |
| 2020 Q2 | 12.32 Billion JPY | -20.36% |
| 2020 Q3 | 11.93 Billion JPY | -3.16% |
| 2020 Q4 | 12.12 Billion JPY | 1.59% |
| 2020 FY | 51.84 Billion JPY | -12.51% |
| 2019 Q4 | 14.63 Billion JPY | -3.31% |
| 2019 Q2 | 13.25 Billion JPY | -18.3% |
| 2019 FY | 59.25 Billion JPY | 2.46% |
| 2019 Q1 | 16.22 Billion JPY | 14.66% |
| 2019 Q3 | 15.13 Billion JPY | 14.17% |
| 2018 Q3 | 15.24 Billion JPY | 16.96% |
| 2018 FY | 57.82 Billion JPY | 6.16% |
| 2018 Q4 | 14.15 Billion JPY | -7.17% |
| 2018 Q2 | 13.03 Billion JPY | -15.37% |
| 2018 Q1 | 15.4 Billion JPY | 15.55% |
| 2017 Q3 | 14.43 Billion JPY | 19.76% |
| 2017 FY | 54.47 Billion JPY | 6.43% |
| 2017 Q1 | 14.66 Billion JPY | 15.93% |
| 2017 Q2 | 12.04 Billion JPY | -17.84% |
| 2017 Q4 | 13.32 Billion JPY | -7.64% |
| 2016 Q1 | 14.13 Billion JPY | 14.93% |
| 2016 FY | 51.18 Billion JPY | 3.63% |
| 2016 Q4 | 12.65 Billion JPY | -7.0% |
| 2016 Q3 | 13.6 Billion JPY | 26.09% |
| 2016 Q2 | 10.78 Billion JPY | -23.7% |
| 2015 Q2 | 10.88 Billion JPY | -14.64% |
| 2015 FY | 49.38 Billion JPY | 2.35% |
| 2015 Q4 | 12.3 Billion JPY | -8.55% |
| 2015 Q1 | 12.75 Billion JPY | 9.52% |
| 2015 Q3 | 13.45 Billion JPY | 23.59% |
| 2014 Q4 | 11.64 Billion JPY | -3.08% |
| 2014 Q1 | 12.81 Billion JPY | 10.95% |
| 2014 Q3 | 12.01 Billion JPY | 1.91% |
| 2014 FY | 48.25 Billion JPY | 3.73% |
| 2014 Q2 | 11.78 Billion JPY | -8.02% |
| 2013 Q2 | 10 Billion JPY | -19.87% |
| 2013 Q4 | 11.54 Billion JPY | -7.46% |
| 2013 Q3 | 12.48 Billion JPY | 24.76% |
| 2013 Q1 | 12.48 Billion JPY | 9.04% |
| 2013 FY | 46.51 Billion JPY | -1.49% |
| 2012 Q3 | 12.54 Billion JPY | 23.69% |
| 2012 FY | 47.22 Billion JPY | 0.0% |
| 2012 Q1 | 13.07 Billion JPY | 14.26% |
| 2012 Q2 | 10.14 Billion JPY | -22.43% |
| 2012 Q4 | 11.44 Billion JPY | -8.75% |
| 2011 Q3 | 13.13 Billion JPY | 0.0% |
| 2011 FY | - JPY | -100.0% |
| 2011 Q4 | 11.44 Billion JPY | -12.87% |
| 2010 FY | 52.58 Billion JPY | -4.79% |
| 2009 FY | 55.22 Billion JPY | -5.87% |
| 2008 FY | 58.66 Billion JPY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Kitanotatsujin Corporation | 14.66 Billion JPY | -326.514% |
| Euglena Co., Ltd. | 44.39 Billion JPY | -40.908% |
| BEAUTY GARAGE Inc. | 29.84 Billion JPY | -109.618% |
| Axas Holdings Co.,Ltd. | 11.71 Billion JPY | -433.779% |
| C.I. Medical Co.,Ltd. | 45.62 Billion JPY | -37.091% |
| Kao Corporation | 1532.57 Billion JPY | 95.919% |
| Niitaka Co., Ltd. | 22.73 Billion JPY | -175.085% |
| Rohto Pharmaceutical Co.,Ltd. | 270.84 Billion JPY | 76.904% |
| Shiseido Company, Limited | 973.03 Billion JPY | 93.571% |
| Lion Corporation | 402.76 Billion JPY | 84.469% |
| Mandom Corporation | 73.23 Billion JPY | 14.585% |
| Ivy Cosmetics Corporation | 2.71 Billion JPY | -2205.009% |
| Milbon Co., Ltd. | 47.76 Billion JPY | -30.965% |
| Nippon Shikizai, Inc. | 15.05 Billion JPY | -315.626% |
| Fancl Corporation | 110.88 Billion JPY | 43.586% |
| KOSÉ Corporation | 300.4 Billion JPY | 79.178% |
| Cota Co., Ltd. | 9.13 Billion JPY | -584.602% |
| HABA Laboratories,Inc. | 12.32 Billion JPY | -407.554% |
| C'bon Cosmetics Co.,Ltd. | 8.49 Billion JPY | -635.995% |
| Pola Orbis Holdings Inc. | 173.3 Billion JPY | 63.906% |
| Adjuvant Holdings Co.,Ltd. | 4.43 Billion JPY | -1309.394% |
| Almado, Inc. | 7.53 Billion JPY | -729.737% |
| I-ne CO., LTD. | 41.64 Billion JPY | -50.21% |
| Premier Anti-Aging Co., Ltd. | 20.35 Billion JPY | -207.245% |
| Liberta Co.,Ltd. | 7.08 Billion JPY | -782.53% |
| AXXZIA Inc. | 12.19 Billion JPY | -413.042% |
| S.T. Corporation | 44.47 Billion JPY | -40.655% |
| Kobayashi Pharmaceutical Co., Ltd. | 173.45 Billion JPY | 63.938% |
| Earth Corporation | 158.34 Billion JPY | 60.496% |
| Sagami Rubber Industries Co., Ltd. | 6.11 Billion JPY | -923.334% |
| Asahi Eito Holdings Co.,Ltd. | 3.51 Billion JPY | -1678.189% |
| Ya-Man Ltd. | 32.02 Billion JPY | -95.33% |
| MTG Co., Ltd. | 60.15 Billion JPY | -3.986% |
| TRANSACTION CO.,Ltd. | 25.04 Billion JPY | -149.737% |
| SHOBIDO Corporation | 20.44 Billion JPY | -205.971% |
| Artnature Inc. | 42.85 Billion JPY | -45.979% |
| Pigeon Corporation | 94.46 Billion JPY | 33.78% |
| Unicharm Corporation | 941.79 Billion JPY | 93.358% |
| Paltac Corporation | 1151.96 Billion JPY | 94.57% |
| CB GROUP MANAGEMENT Co., Ltd. | 147.28 Billion JPY | 57.53% |